Research has shown psilocybin to have potential to treat a range of psychiatric and behavioral disorders, although it’s yet to receive FDA approval for anything.
Its potential indications include depression, obsessive-compulsive disorder, quitting smoking, alcohol addiction, cocaine addiction, cluster headaches, and cancer-related or other end-of-life psychological distress.
High-profile initiatives have also popped up in recent months in Denver, Colorado, and Oregon to decriminalize psilocybin mushrooms.
However, experts say they’re unlikely to pass.
Psilocybin mushrooms remain a Schedule I drug according to the Drug Enforcement Agency, meaning they’re classified as having “no currently accepted medical use
... read more at: https://www.healthline.com/health-news/benefits-of-medical-mushrooms